tiprankstipranks
Trending News
More News >
Aptamer Group Plc (GB:APTA)
LSE:APTA
Advertisement

Aptamer Group Plc (APTA) Price & Analysis

Compare
5 Followers

APTA Stock Chart & Stats


Aptamer Group Plc News

APTA FAQ

What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest share price was 0.20p and its highest was 0.77p in the past 12 months.
    What is Aptamer Group Plc’s market cap?
    Aptamer Group Plc’s market cap is £17.70M.
      When is Aptamer Group Plc’s upcoming earnings report date?
      Aptamer Group Plc’s upcoming earnings report date is Oct 21, 2025 which is in 59 days.
        How were Aptamer Group Plc’s earnings last quarter?
        Aptamer Group Plc released its earnings results on Mar 11, 2025. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
          Is Aptamer Group Plc overvalued?
          According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Aptamer Group Plc pay dividends?
            Aptamer Group Plc does not currently pay dividends.
            What is Aptamer Group Plc’s EPS estimate?
            Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Aptamer Group Plc have?
            Aptamer Group Plc has 2,660,978,300 shares outstanding.
              What happened to Aptamer Group Plc’s price movement after its last earnings report?
              Aptamer Group Plc reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Aptamer Group Plc?
                Currently, no hedge funds are holding shares in GB:APTA

                Company Description

                Aptamer Group Plc

                Aptamer Group Plc (APTA) is a biotechnology company specializing in the development and application of aptamer technology. The company operates within the life sciences sector, focusing on the discovery and development of aptamers, which are synthetic molecules that can bind to specific targets such as proteins, cells, and small molecules with high affinity and specificity. Aptamer Group provides custom aptamer discovery and development services for research, diagnostics, and therapeutic applications across various industries including pharmaceuticals, diagnostics, and bio-manufacturing.

                Aptamer Group Plc (APTA) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                ValiRx plc
                Oxford BioDynamics
                Fusion Antibodies Plc

                Ownership Overview

                7.21%92.79%
                Mutual Funds
                ― Other Institutional Investors
                92.79% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis